PersisGen

PersisGen is a leading biopharmaceutical accelerator and manufacturer based in Iran, specializing in the development and production of biosimilars, vaccines, and advanced cell therapies. The company operates as a strategic hub that supports biotech startups through its state-of-the-art R&D and GMP manufacturing facilities, focusing on high-value biologics for oncology, autoimmune diseases, and bone health. PersisGen has successfully commercialized several biosimilar products and played a critical role in regional vaccine development, including the SpikoGen COVID-19 vaccine. By bridging the gap between laboratory research and industrial-scale production, the company aims to increase the accessibility of complex biological treatments in the Middle East and North Africa (MENA) region.